ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) CEO Stephen Davis Sells 11,427 Shares

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) CEO Stephen Davis sold 11,427 shares of the company’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $16.94, for a total transaction of $193,573.38. Following the transaction, the chief executive officer now owns 155,231 shares of the company’s […]

Related Keywords

Alger ,Algeria ,Canada ,Mizuho ,Sakhalinskaya Oblast ,Russia ,United States ,Robertw Baird ,Stephen Davis ,Pharmaceuticals Price Performance ,Pharmaceuticals Company Profile ,Pharmaceuticals Daily ,Norges Bank ,Eventide Asset Management ,Acadia Pharmaceuticals Inc ,Pharmaceuticals Inc ,Mg Investment Management Ltd ,Royal Bank ,Fred Alger Management ,Nasdaq ,Get Free Report ,Alger Management ,Asset Management ,Acadia Pharmaceuticals ,Nasdaq Acad ,Facad ,Medical ,Insider Trading ,Nsider Trades ,Stocks ,